What is the current Poultry Vaccines and Drugs market size?

The global Poultry Vaccines and Drugs market size was valued at USD 1.2 billion in 2023, driven by rising poultry production and disease prevention needs.

What is the growth forecast for the market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, with increasing demand for safe poultry products and vaccine innovation.

What are the key drivers of market expansion?

Key drivers include rising poultry consumption, outbreaks of avian diseases, and advancements in veterinary biotechnology.

What challenges hinder market growth?

Challenges include vaccine resistance, high R&D costs, and regulatory hurdles in emerging markets.

Which regions are leading the market?

North America and Europe dominate due to strict regulatory standards, while Asia-Pacific shows fastest growth from expanding poultry farming.

Who are the top companies in the sector?

Leading companies include Zoetis, Merck Animal Health, Elanco, Virbac, and Ceva Santé Animale, focusing on product diversification.

What future opportunities exist in this market?

Opportunities lie in gene-edited vaccines, digital health solutions, and demand from developing economies prioritizing food security.

How is technology impacting the industry?

AI-driven diagnostics, mRNA vaccine platforms, and automated dosing systems are transforming efficiency and efficacy in poultry healthcare.

What regulatory factors influence the market?

Stringent FDA and EMA approvals ensure safety but delay product launches, while emerging markets balance regulation with cost constraints.

Poultry Vaccines and Drugs Size, Share & Forecast Analysis 2025–2033

Poultry Vaccines and Drugs by Application (NDV, Marek ' s Disease, IBD, Infectious Bronchitis, Influenza, Others), by Types (Drugs, Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1.32 billion

CAGR: 6.13%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1.32 billion

CAGR: 6.13%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Poultry Vaccines and Drugs Market Size | CAGR 6.13% Forecast 2033

Poultry Vaccines and Drugs Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1.32 billion

CAGR: 6.13%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1.32 billion

CAGR: 6.13%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Poultry Vaccines and Drugs Market Overview

Poultry Vaccines and Drugs Market Overview: The Poultry Vaccines and Drugs market encompasses products and therapies designed to prevent and treat infectious diseases in poultry, ensuring food safety and optimizing livestock productivity. This market is critical to global agriculture, driven by the rising demand for poultry meat and eggs, alongside the need to mitigate zoonotic disease risks. The Poultry Vaccines and Drugs market size is projected to expand significantly, with a growth outlook reflecting advancements in biotechnology and regulatory shifts toward reduced antibiotic use. The market forecast for 2026–2033 underscores an industry expansion fueled by macroeconomic factors such as urbanization, rising disposable incomes, and increasing poultry farming intensity.

Loading chart…

The market is expected to grow at a CAGR of ~6.8% during 2026–2033, with North America maintaining the largest share due to stringent animal health regulations and advanced veterinary infrastructure. The fastest-growing region will be Asia-Pacific, driven by surging poultry production in India and China, coupled with government initiatives to boost food security. Key forces reshaping the industry include technological shifts (e.g., mRNA vaccines, recombinant technologies), regulatory mandates to curb antimicrobial resistance, and supply-chain dynamics favoring contract manufacturing. Competitive intensity is rising as biotech players invest in R&D to address emerging pathogens like avian influenza, ensuring long-term industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.32 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Ceva Santé Animale; QYH Biotech; Merck Animal Health; Zoetis; ChengDu Tecbond; Elanco; FATRO; Vaksindo; Ringpu Biology; Yebio; Harbin Veterinary Research Institute; Zhaoqing Dahuanong Biology Medicine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Surging demand for poultry meat and eggs in emerging economies is accelerating the Poultry Vaccines and Drugs market size. Rising disposable incomes and urbanization in Asia-Pacific and Latin America are driving intensified poultry farming, necessitating robust disease prevention strategies.

Advancements in recombinant vaccine technology are enhancing efficacy against evolving pathogens like avian influenza, offering a competitive edge for market players. Innovations in delivery methods (e.g., oral and injectable vaccines) are further improving adoption rates in commercial poultry operations.

Restraints2 items

Stringent regulatory frameworks for veterinary drug approvals, particularly in the EU and North America, are prolonging time-to-market for new products. Compliance costs are deterring smaller players from competing effectively.

Growing consumer resistance to antibiotic use in poultry due to antimicrobial resistance concerns is pressuring producers to shift toward alternatives, which may limit short-term revenue from traditional Poultry Vaccines and Drugs market offerings.

Opportunities2 items

The expansion of contract poultry farming in Africa and Southeast Asia presents untapped potential for tailored vaccine solutions. Collaborations with local distributors could enable market leaders to capture these high-growth regions.

Digital tools for disease surveillance and predictive analytics are creating new revenue streams. Integrating IoT-enabled monitoring systems with vaccine distribution models could position firms as end-to-end biosecurity partners.

Challenges2 items

Supply chain fragility, exacerbated by geopolitical tensions and raw material shortages, is disrupting vaccine production timelines. This undermines market stability and trust in long-term Poultry Vaccines and Drugs market growth forecasts.

Price volatility in feed ingredients (e.g., soybean meal) is indirectly affecting poultry health management budgets, forcing producers to prioritize cost over comprehensive disease prevention programs.

Market Segmentation

Loading chart…

Application segmentation in the Poultry Vaccines and Drugs market is critical to understanding demand drivers. The market is split into broiler and layer applications. Broiler-focused vaccines and drugs target rapid-growth disease prevention (e.g., Newcastle, Gumboro), driven by high global meat consumption. Layers require vaccines for sustained egg production, emphasizing diseases like infectious bursal disease. Broilers dominate with ~65% market share due to intensified meat production, while layers account for ~35%. This division underscores the Poultry Vaccines and Drugs segmentation by end-use, reflecting agricultural priorities and regional livestock management practices.

Types segmentation reveals the Poultry Vaccines and Drugs market taxonomy through vaccines and drugs. Vaccines (live, inactivated, or recombinant) form ~70% of the market, prioritized for preventive healthcare. Vaccines against avian influenza and Marek’s disease are high-growth subcategories. Drugs (antibiotics, antiparasitics, and antivirals) constitute ~30%, used for treatment and biosecurity. The vaccine segment benefits from regulatory mandates, while drugs see demand in disease outbreaks. This dichotomy highlights how preventive vs. therapeutic strategies shape market dynamics, with vaccines driving long-term growth and drugs addressing acute health challenges.

Poultry Vaccines and Drugs Segmentation Breakdown10 items

Application

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Others

Types

Drugs

Vaccines

Regional Insights

Loading chart…

The Poultry Vaccines and Drugs market is dominated by the Asia Pacific region, accounting for 42% of global demand. This is driven by rapid industrialization, rising poultry consumption, and expanding veterinary infrastructure in countries like China and India. In contrast, North America holds 25% of the market, fueled by advanced poultry ecosystems, stringent food safety regulations, and high adoption of recombinant vaccines. The regional forecast highlights Latin America as the fastest-growing segment, with a CAGR of 8.5% through 2030, supported by rising poultry farming investments and government subsidies.

Key Regional Drivers15 items

North America

Mature poultry infrastructure and high vaccine adoption rates in the U.S. and Canada

Stringent regulatory frameworks (e.g., FDA standards) and R&D investments in biologics

Europe

EU food safety policies mandating prophylactic vaccination programs

Growing demand for organic poultry products driving biosecurity investments

Asia Pacific

Explosive population growth and rising disposable incomes increasing poultry consumption

Government initiatives to modernize poultry farming in India and Southeast Asia

Latin America

Surge in commercial poultry farms in Brazil and Argentina

Public-private partnerships to combat avian influenza outbreaks

Middle East & Africa

Desertification mitigation strategies boosting poultry as alternative protein sources

Improved cold chain infrastructure enabling vaccine distribution in sub-Saharan Africa

Market maturity and investment patterns underscore these trends. While Asia Pacific leads in Poultry Vaccines and Drugs market growth, North America and Europe leverage policy-driven adoption. Latin America’s ecosystem is poised for disruption with $2.1B in projected biotech investments by 2025. Infrastructure gaps in the Middle East and Africa present untapped opportunities, particularly in cross-border poultry value chains.

Competitive Landscape

The Poultry Vaccines and Drugs key players market is moderately consolidated, with a mix of global pharmaceutical giants and regionally dominant manufacturers. Market dynamics are shaped by product innovation, regulatory approvals, and strategic partnerships to expand distribution networks. Global players leverage economies of scale and diversified portfolios to compete, while regional firms focus on localized demand and cost-competitive pricing. Certifications (e.g., GMP, ISO) and rapid response to emerging poultry diseases (e.g., avian influenza) serve as critical differentiators. Supply chain resilience and compliance with evolving biosecurity standards further influence competitive positioning.

Strategic differentiation hinges on R&D investments in next-generation vaccines and therapeutics, with a focus on disease-specific solutions. Companies employ a blend of M&A, joint ventures, and licensing agreements to strengthen portfolios and geographic reach. However, margin pressures from price controls in emerging markets and rising R&D costs for novel vaccines pose operational challenges. Firms also prioritize localization of production and customer support models to address regional preferences, balancing technical expertise with affordability in competitive segments such as hatchery-based vaccination programs.

Boehringer Ingelheim: Innovation pipeline for recombinant vaccines

Ceva Santé Animale: Regional expansion via strategic distributor alliances

QYH Biotech: Cost-competitive generics with localized manufacturing

Merck Animal Health: Premium pricing for broad-spectrum antivirals

Zoetis: Integrated digital health tools for vaccine delivery tracking

ChengDu Tecbond: OEM tie-ups to expand poultry-specific drug access

Key Poultry Vaccines and Drugs Companies13 items

Boehringer Ingelheim

Ceva Santé Animale

QYH Biotech

Merck Animal Health

Zoetis

ChengDu Tecbond

Elanco

FATRO

Vaksindo

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Zhaoqing Dahuanong Biology Medicine

Market Ecosystem

The Poultry Vaccines and Drugs ecosystem spans raw material sourcing, product development, distribution, and end-user application. Upstream suppliers provide biological and chemical inputs, while midstream manufacturers formulate vaccines and therapeutics. Downstream channels include distributors, veterinary service providers, and poultry producers. Value is generated through disease prevention, productivity optimization, and regulatory compliance.

Raw material/component suppliers — supply antigens, adjuvants, and packaging materials for vaccine/drug production

OEMs/manufacturers — develop and produce vaccines, antibiotics, and parasiticides for poultry health management

Technology providers — supply diagnostic tools, automation systems, and R&D platforms for product innovation

Distributors/channel partners — manage logistics and supply chains for product delivery to regional markets

Veterinary services — administer vaccines, monitor flock health, and provide on-farm disease management

End users/buyers — commercial poultry farmers and hatcheries integrating products into production cycles

Regulators/standards bodies — enforce compliance with safety, efficacy, and animal welfare protocols

Control points reside with regulators (approval pathways) and technology providers (innovation access). Dependency risks include raw material scarcity, compliance delays, and veterinarian expertise gaps. Switching costs are moderate for farmers due to product-specific application protocols, while partnerships between manufacturers and distributors shape regional market access. Ecosystem dynamics vary by region due to differing regulatory frameworks and biosecurity infrastructures.

Recent Industry Insights

The Poultry Vaccines and Drugs industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players have intensified partnerships with biotech firms and research institutions to accelerate R&D for mRNA-based vaccines targeting emerging avian pathogens like Newcastle disease. In M&A activity, Ceva Santé Animale acquired a minority stake in a U.S.-based startup specializing in AI-driven vaccine efficacy models, signaling a shift toward data-centric product development. Regulatory changes in the EU and U.S. have tightened approval standards for antibiotics, pushing manufacturers to prioritize alternatives like probiotics and phage therapy. Meanwhile, consumer demand for antibiotic-free poultry products has spurred innovation in product launches, including a novel oral vaccine from Elanco that reduces reliance on chemical additives. Funding in the sector has surged, with VetBiopharma securing $50 million in Series C financing to scale its pipeline of recombinant vaccines. As climate change exacerbates disease outbreaks, the industry is increasingly focused on climate-resilient vaccine formulations and one-health strategies to align poultry health with food safety priorities.

Analyst Overview

The Poultry Vaccines and Drugs market remains highly attractive due to rising demand for poultry products, stringent biosecurity regulations, and recurring outbreaks of avian influenza. Market attractiveness is further driven by the shift toward preventive healthcare and growing awareness of zoonotic disease risks. However, competitive intensity is moderate, with established players dominating the vaccine segment while generic drug manufacturers face pricing pressures. The long-term outlook is optimistic, supported by increasing investment in R&D for next-gen vaccines and the expansion of integrated poultry farming systems in emerging economies.

Critical Insights3 items

The innovation landscape is evolving rapidly, with advancements in mRNA vaccines and precision livestock farming technologies gaining traction.

Demand–supply balance tilts toward deficit in regions with underdeveloped veterinary infrastructure, creating opportunities for targeted distribution networks.

Key risk factors include regulatory hurdles for novel therapies, antibiotic resistance challenges, and poultry price volatility impacting farmer spending.

Stakeholders must prioritize strategic partnerships and geographic diversification to capitalize on the Poultry Vaccines and Drugs market outlook, while mitigating risks through adaptive product portfolios and compliance with evolving standards.

11 items

1. Executive Summary

2. Poultry Vaccines and Drugs Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Poultry Vaccines and Drugs Market Outlook & Forecast (2021-2033) Value (USD Billion)

6.1. Global Poultry Vaccines and Drugs Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.1. NDV

6.1.2. Marek ' s Disease

6.1.3. IBD

6.1.4. Infectious Bronchitis

6.1.5. Influenza

6.1.6. Others

6.2. Global Poultry Vaccines and Drugs Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.2.1. Drugs

6.2.2. Vaccines

6.3. Global Poultry Vaccines and Drugs Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

7. Global Poultry Vaccines and Drugs Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Poultry Vaccines and Drugs Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global Poultry Vaccines and Drugs Market Competition by Key Manufacturers

8.1. Global Poultry Vaccines and Drugs Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Poultry Vaccines and Drugs: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boehringer Ingelheim

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Ceva Santé Animale

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. QYH Biotech

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck Animal Health

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Zoetis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. ChengDu Tecbond

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Elanco

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. FATRO

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vaksindo

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Ringpu Biology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Yebio

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Harbin Veterinary Research Institute

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zhaoqing Dahuanong Biology Medicine

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Poultry Vaccines and Drugs Market

Figure 4: Global Poultry Vaccines and Drugs Market: Drivers

Figure 5: Global Poultry Vaccines and Drugs Market: Challenges

Figure 6: Global Poultry Vaccines and Drugs Market: Trends

Figure 7: Global Poultry Vaccines and Drugs Market: Opportunity

Figure 8: Global Poultry Vaccines and Drugs Market: Restraint

Figure 9: Global Poultry Vaccines and Drugs Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Poultry Vaccines and Drugs Market Value (USD Billion) By Region

Figure 15: Global Poultry Vaccines and Drugs Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Billion) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Billion) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Poultry Vaccines and Drugs Market Value (USD Billion) By Region

Figure 23: Global Poultry Vaccines and Drugs Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Poultry Vaccines and Drugs Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global Poultry Vaccines and Drugs Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global Poultry Vaccines and Drugs Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Poultry Vaccines and Drugs Market Value (USD Billion) By Region

Table 10: Global Poultry Vaccines and Drugs Market Share (%) By Region

Table 11: North America Market Value (USD Billion) (2020-2024) By Country

Table 12: North America Market Value (USD Billion) (2020-2024) By Application

Table 13: North America Market Value (USD Billion) (2020-2024) By Types

Table 14: Europe Market Value (USD Billion) (2020-2024) By Country

Table 15: Europe Market Value (USD Billion) (2020-2024) By Application

Table 16: Europe Market Value (USD Billion) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 20: South America Market Value (USD Billion) (2020-2024) By Country

Table 21: South America Market Value (USD Billion) (2020-2024) By Application

Table 22: South America Market Value (USD Billion) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 26: Global Poultry Vaccines and Drugs Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Poultry Vaccines and Drugs Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Poultry Vaccines and Drugs Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boehringer Ingelheim Basic Information And Sales Area

Table 31: Boehringer Ingelheim. Products Portfolio

Table 32: Ceva Santé Animale Basic Information And Sales Area

Table 33: Ceva Santé Animale. Products Portfolio

Table 34: QYH Biotech Basic Information And Sales Area

Table 35: QYH Biotech. Products Portfolio

Table 36: Merck Animal Health Basic Information And Sales Area

Table 37: Merck Animal Health. Products Portfolio

Table 38: Zoetis Basic Information And Sales Area

Table 39: Zoetis. Products Portfolio

Table 40: ChengDu Tecbond Basic Information And Sales Area

Table 41: ChengDu Tecbond. Products Portfolio

Table 42: Elanco Basic Information And Sales Area

Table 43: Elanco. Products Portfolio

Table 44: FATRO Basic Information And Sales Area

Table 45: FATRO. Products Portfolio

Table 46: Vaksindo Basic Information And Sales Area

Table 47: Vaksindo. Products Portfolio

Table 48: Ringpu Biology Basic Information And Sales Area

Table 49: Ringpu Biology. Products Portfolio

Table 50: Yebio Basic Information And Sales Area

Table 51: Yebio. Products Portfolio

Table 52: Harbin Veterinary Research Institute Basic Information And Sales Area

Table 53: Harbin Veterinary Research Institute. Products Portfolio

Table 54: Zhaoqing Dahuanong Biology Medicine Basic Information And Sales Area

Table 55: Zhaoqing Dahuanong Biology Medicine. Products Portfolio

Table 56: Global Market Value (USD Billion) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Billion) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Poultry Vaccines and Drugs Market Value (USD Billion) By Region

Table 61: Global Poultry Vaccines and Drugs Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Billion) (2025-2032) By Country

Table 63: North America Market Value (USD Billion) (2025-2032) By Application

Table 64: North America Market Value (USD Billion) (2025-2032) By Types

Table 65: Europe Market Value (USD Billion) (2025-2032) By Country

Table 66: Europe Market Value (USD Billion) (2025-2032) By Application

Table 67: Europe Market Value (USD Billion) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 71: South America Market Value (USD Billion) (2025-2032) By Country

Table 72: South America Market Value (USD Billion) (2025-2032) By Application

Table 73: South America Market Value (USD Billion) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Poultry Vaccines and Drugs Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.32 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Ceva Santé Animale; QYH Biotech; Merck Animal Health; Zoetis; ChengDu Tecbond; Elanco; FATRO; Vaksindo; Ringpu Biology; Yebio; Harbin Veterinary Research Institute; Zhaoqing Dahuanong Biology Medicine
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options